» Articles » PMID: 32107824

Environmental Factors in the Pathogenesis of Primary Sjögren's Syndrome

Overview
Journal J Intern Med
Specialty General Medicine
Date 2020 Feb 29
PMID 32107824
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

Primary Sjögren's syndrome (SS) is a systemic autoimmune disease in which exocrine organs, primarily the salivary and lacrimal glands, are targets of chronic inflammation, leading to severe dryness of eyes and mouth. Fatigue and arthralgia are also common, and extraglandular manifestations involving the respiratory, nervous and vascular systems occur in a subset of patients. Persistent activation of the type I interferon system, and autoreactive B and T cells with production of disease-associated autoantibodies are central to the pathogenesis. Genetic polymorphisms that associate with an increased risk of SS have been described, though the risk-increase contributed by the respective variant is generally low. It is thus becoming increasingly clear that genetics cannot alone account for the development of SS and that other, presumably exogenous, factors must play a critical role. Relatively few studies have investigated exposure to potential risk factors prior to SS disease onset. Rather, many factors have been studied in prevalent cases. In this review, we summarize current literature on exogenous factors in the pathogenesis of SS including infections, hormones, smoking, solvents and additional compounds. We delineate for which factors there is current evidence of increased disease risk, and for which our present knowledge is confined to suggesting their role in SS pathogenesis. Finally, we outline future perspectives in the continued search for environmental risk factors for SS, a research area of great importance considering the possibilities for preventive measures.

Citing Articles

Lipid Metabolism: An Emerging Player in Sjögren's Syndrome.

Chang K, Luo P, Guo Z, Yang L, Pu J, Han F Clin Rev Allergy Immunol. 2025; 68(1):15.

PMID: 39934534 PMC: 11813826. DOI: 10.1007/s12016-025-09023-8.


Immune and non-immune mediators in the fibrosis pathogenesis of salivary gland in Sjögren's syndrome.

Ma D, Feng Y, Lin X Front Immunol. 2024; 15:1421436.

PMID: 39469708 PMC: 11513355. DOI: 10.3389/fimmu.2024.1421436.


Relationship Between Perfluoroalkyl Acids in Human Serum and Sjogren's Syndrome: A Case-Control Study of Populations in Hangzhou, China.

Zhao Y, Hu S, Jin H, Fan C, Liao K, Zhang S Toxics. 2024; 12(10).

PMID: 39453184 PMC: 11511288. DOI: 10.3390/toxics12100764.


Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders.

Song Y, Li J, Wu Y Signal Transduct Target Ther. 2024; 9(1):263.

PMID: 39362875 PMC: 11452214. DOI: 10.1038/s41392-024-01952-8.


Patients' recollection about the onset of Sjögren's disease - a mixed methods study on the patients' perspective.

Lackner A, Dreo B, Hermann J, Zenz S, Fessler J, Thiel J Arthritis Res Ther. 2024; 26(1):169.

PMID: 39342382 PMC: 11438132. DOI: 10.1186/s13075-024-03404-8.